 |
|
|
| |
RO7049389, a core protein allosteric modulator, demonstrates robust decline in HBV DNA and HBV RNA in chronic HBV infected patients
|
| |
| |
EASL 2019 Vienna April
Man-Fung Yuen1, Christian Schwabe2,TawesakTanwandee3,, YuyanJin4, Lu Gao4, XueZhou4, SudipDas5,Yifan Wang4, Annabelle Lemenuel-Diot6, Valerie Cosson6, Sheng Feng4, Dominik Meinel6, MingfenZhu4, QingyanBo4, Edward Gane7
1 The University of Hong Kong, Hong Kong, China; 2.Auckland Clinical Studies, Auckland, New Zealand; 3 MahidolUniversity, Bangkok, Thailand; 4 Roche Innovation Centre Shanghai, Shanghai, China; 5 Roche Products Limited, Shire Park, United Kingdom; 6 Roche Innovation Centre Basel, Basel, Switzerland; 7 The University of Auckland, Auckland, New Zealand
|
| |
|
|
|
|
|
